Cogent Biosciences (COGT) Assets Average (2018 - 2026)
Cogent Biosciences (COGT) posted quarterly Assets Average of $920.3 million for Q1 2026, up 200.9% year-over-year from $305.8 million in Q1 2025, and up 34.99% quarter-over-quarter from $681.8 million in Q4 2025.
Cogent Biosciences (COGT) Assets Average (2018 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Assets Average for 9 consecutive years, with $920.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 200.9% year-over-year to $920.3 million; the TTM figure through Mar 2026 stood at $920.3 million (up 200.9% YoY), while the FY2025 annual figure was $632.8 million, up 97.32% from the prior year.
- Assets Average improved to $920.3 million in Q1 2026 per COGT's latest filing, from $681.8 million in the prior quarter.
- Across five years, Assets Average topped out at $920.3 million in Q1 2026 and bottomed at $219.5 million in Q1 2022.
- Historically, Assets Average has averaged $390.4 million across 5 years, with a median of $348.8 million in 2022.
- Annual changes were most pronounced in 2025 — Assets Average slumped 38.35% — and 2026, when it soared 200.9%.
- Cogent Biosciences' Assets Average stood at $316.2 million in 2022, then increased by 5.77% to $334.4 million in 2023, then rose by 6.43% to $356.0 million in 2024, then jumped by 91.53% to $681.8 million in 2025, then surged by 34.99% to $920.3 million in 2026.
- Business Quant data shows COGT's Assets Average at $920.3 million in Q1 2026, $681.8 million in Q4 2025, and $350.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 868.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 868.78 Mn |
| Mar 31, 2026 | 920.31 Mn |
| Dec 31, 2025 | 681.77 Mn |
| Sep 30, 2025 | 350.38 Mn |
| Jun 30, 2025 | 279.31 Mn |
| Mar 31, 2025 | 305.85 Mn |
| Dec 31, 2024 | 355.96 Mn |
| Sep 30, 2024 | 406.98 Mn |
| Jun 30, 2024 | 453.02 Mn |
| Mar 31, 2024 | 394.77 Mn |
| Dec 31, 2023 | 334.44 Mn |
| Sep 30, 2023 | 373.91 Mn |
| Jun 30, 2023 | 327.78 Mn |
| Mar 31, 2023 | 282.00 Mn |
| Dec 31, 2022 | 316.19 Mn |
| Sep 30, 2022 | 348.81 Mn |
| Jun 30, 2022 | 286.46 Mn |
| Mar 31, 2022 | 219.48 Mn |
| Dec 31, 2021 | 223.74 Mn |
| Sep 30, 2021 | 221.95 Mn |